A7E-26213-02197
3 vaccinations
3 coded responses
37 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 787 / TX
- Registered
- 2021-03-24
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-24
Registered in v-safe
-
2021-03-24
Dose 1 — Pfizer-BioNTech
- 2021-03-24
-
2021-03-25
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2021-03-26
- 2021-03-27
-
2021-03-28
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2021-03-29
- 2021-03-31
- 2021-04-07
-
2021-04-14
Dose 2 — Pfizer-BioNTech
- 2021-04-14
-
2021-04-15
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Itching · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-16
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-04-17
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-04-18
- 2021-04-19
- 2021-04-20
- 2021-04-23
- 2021-04-28
- 2021-05-05
- 2021-05-12
- 2021-05-21
- 2021-05-26
-
2021-07-14
Survey response — 3 months, dose 2MedDRA: Fatigue, Headache, Nasopharyngitis, Oropharyngeal pain, Rhinorrhoea, SARS-CoV-2 test negative — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Mild cold, runny nose, headache, sore throat, fatigue. 5 days of symptoms.. negative COVID rapid testMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-10-13
-
2021-12-07
Dose 3 — Pfizer-BioNTech
- 2021-12-07
-
2021-12-08
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-12-10
- 2021-12-11
- 2021-12-12
- 2021-12-13
- 2021-12-16
- 2021-12-21
-
2021-12-28
Survey response — day 21, dose 3MedDRA: Diarrhoea, Vomiting — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Food poisoning? (Vomiting and diahrea less than 12 hours long)MedDRA releases: 2024-11 · check-in free text available
- 2022-01-04
- 2022-01-11
- 2022-01-20
-
2022-06-07
Survey response — 6 months, dose 3MedDRA: COVID-19, Cough, Fatigue, Pyrexia, Urticaria — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Covid - cough, exhaustion, fever, hivesMedDRA releases: 2024-11 · check-in free text available
-
2022-06-07
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-06-08
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-12-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-24 | Pfizer-BioNTech | |
| 2 | 2021-04-14 | Pfizer-BioNTech | |
| 3 | 2021-12-07 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 9 — 3 months, dose 2
Symptoms: Mild cold, runny nose, headache, sore throat, fatigue. 5 days of symptoms.. negative COVID rapid test
Release 10 — day 21, dose 3
Symptoms: Food poisoning? (Vomiting and diahrea less than 12 hours long)
Release 11 — 6 months, dose 3
Symptoms: Covid - cough, exhaustion, fever, hives
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Pain | ○ | ○ | ○ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test negative | ✓ | ✓ | ✓ |
| SD | Urticaria | · | · | ✓ |
| SD | Vomiting | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release